BOLOGNA, Italy and MORRISTOWN, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. (“Intercept”) announced today the completion of the ...
Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver disease drug Ocaliva is under serious threat. Looking to assess whether Ocaliva ...
Shares of Intercept Pharmaceuticals, Inc. ICPT soared 79.2% after Italy-based pharmaceutical company Alfasigma S.p.A. announced an agreement to acquire Intercept for $19.00 per share in cash. The ...
BOLOGNA, Italy--(BUSINESS WIRE)-- Alfasigma S.p.A. (“Alfasigma”) today announced that its wholly-owned subsidiary, Interstellar Acquisition Inc., a Delaware corporation (“Purchaser”), has commenced a ...
Sign up for the daily CJR newsletter. On Wednesday, First Look Media delivered the latest in a flurry of bad news for digital media: the company, which includes The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results